Enzalutamide in castration-resistant prostate cancer patients progressing after docetaxel and abiraterone

Andres Jan Schrader*, Martin Boegemann, Carsten H. Ohlmann, Thomas J. Schnoeller, Laura Maria Krabbe, Turkan Hajili, Florian Jentzmik, Michael Stoeckle, Mark Schrader, Edwin Herrmann, Marcus V. Cronauer

*Corresponding author for this work
198 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Enzalutamide in castration-resistant prostate cancer patients progressing after docetaxel and abiraterone'. Together they form a unique fingerprint.

Medicine & Life Sciences